A significant step was taken today to bolster the National Capital Region’s standing as a hub for advanced research and development, as a high-level delegation from Gautam Buddha University (GBU) met ...

WELLESLEY HILLS, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, ...

The bond market tends to signal broad economic developments well in advance. Emily Bary and Tomi Kilgore explained how the bond market has been indicating that the build-out of generative artificial ...

Tom Brady recently announced that he cloned his dog. Learn more about the wild world of pet cloning and how much it costs.

Learn more about whether Kymera Therapeutics, Inc. or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the World. LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a lea ...

TO drive innovation and regulatory responsiveness in agricultural biotechnology, a high-level forum was organized on Bridging Biotechnology Innovation and Regulations: Orientation on Microbial-based ...

Long before he found himself in the middle of a multibillion-dollar takeover battle for a coveted new weight-loss drug, Whit ...

October 2025 saw a wave of M&As and biotech deals in various therapeutic fields, particularly for therapies addressing ...

How do regulators address concerns in the court of evidentiary decision making -- and of public opinion -- surrounding ...

Former NFL superstar Tom Brady has revealed that his current dog, named Junie, is actually a clone of his former pet, Lua, ...

The Board of Directors of Aquaporin A/S ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, hereby provides an update on ...